Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 SEK | +2.72% | +3.03% | -21.11% |
Business Summary
Number of employees: 6
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Lipid-related Drugs
100.0
%
| 0 | nan % | 16 | 100.0 % | - |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 0 | nan % | 16 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 45 | 05/04/10 | |
Lars Ole Öhman
CHM | Chairman | 67 | 31/12/11 |
Hugo Petit
DFI | Director of Finance/CFO | 54 | 31/12/22 |
Eva Arlander
COO | Chief Operating Officer | 60 | 31/12/20 |
Andreas Vretblom
AUD | Comptroller/Controller/Auditor | - | - |
Stefan Pierrou
PRN | Corporate Officer/Principal | 59 | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Ole Öhman
CHM | Chairman | 67 | 31/12/11 |
Director/Board Member | 52 | 31/12/20 | |
David Westberg
BRD | Director/Board Member | 64 | 31/12/22 |
Director/Board Member | 61 | 18/05/22 | |
Johannes Hulthe
BRD | Director/Board Member | 54 | 31/12/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 126,422,281 | 89,026,825 ( 70.42 %) | 0 | 70.42 % |
Company contact information
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.11% | 3.91M | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- LPGO Stock
- Company Lipigon Pharmaceuticals AB